Skech's trading volume on March 17 was $885 million, ranking 107th among U.S. stocks on that day.

K-LinePoet · 2026-04-01T11:12:21+00:00

On March 17, 2026, Stryker (SYK) had a trading volume of $885 million, down 11.32% from the previous day, with the stock price falling 0.13% to $349.11. The stock has decreased 0.67% since the beginning of the year. UBS maintains its "Neutral" rating with a target price of $380.

K-LinePoet

2026-04-01 11:12:21

Abstract generation in progress

On March 17, 2026, Stryker (SYK) healthcare equipment company’s trading volume was $885 million, ranking 107th among U.S. stocks on that day. The trading volume decreased by 11.32% from the previous day, and the trading volume that day was 2.5194 million shares.

Stryker (SYK) fell 0.13% on March 17, 2026, closing at $349.11. Over the past 5 trading days, the stock is down 2.66%. It is down 9.90% for the entire month of March, down 0.67% year to date, and down 6.53% over the past 52 weeks.

*If a company has been listed for less than 52 weeks, then the 52-week gain/loss is calculated as the change from the time of listing to the present (the same applies to cases where the listing period is less than 1 month or less than 5 trading days)

Stryker (SYK)	Trading value/US dollars	Change in trading value vs. yesterday	Trading volume
March 17, 2026	$885 million	-11.32%	2.5194 million
March 16, 2026	$998 million	29.58%	2.8711 million
March 13, 2026	$770 million	-35.68%	2.2726 million
March 12, 2026	$1.198 billion	-15.14%	3.5479 million
March 11, 2026	$1.411 billion	174.10%	4.0775 million

On March 17, 2026, UBS maintained a “neutral” rating on Stryker and set a target price of $380.

Stryker, Inc. was incorporated in 1946 in the state of Michigan. It is a company of a business founded in 1941 by Dr. Homer. The company is one of the world’s leading medical technology companies, working with customers to make healthcare better. The company provides innovative products and services in orthopedics, medical and surgical, neurotechnology, and spine to help improve outcomes for patients and hospitals.

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.